Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
16.43
+0.09 (0.55%)
Mar 25, 2026, 8:55 AM EDT - Market open
Fulgent Genetics Market Cap
Fulgent Genetics has a market cap or net worth of $513.12 million as of March 25, 2026. Its market cap has decreased by -10.47% in one year.
Market Cap
513.12M
Enterprise Value
-187.00M
1-Year Change
-10.47%
Ranking
Category
Stock Price
$16.43
Market Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $513.12M, an increase of 227.87%. That is a compound annual growth rate of 13.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 510.00M | -37.20% |
| Dec 31, 2025 | 812.10M | 43.76% |
| Dec 31, 2024 | 564.90M | -34.06% |
| Dec 29, 2023 | 856.70M | -2.28% |
| Dec 30, 2022 | 876.70M | -70.78% |
| Dec 31, 2021 | 3.00B | 137.27% |
| Dec 31, 2020 | 1.26B | 423.90% |
| Dec 31, 2019 | 241.40M | 321.29% |
| Dec 31, 2018 | 57.30M | -26.63% |
| Dec 29, 2017 | 78.10M | -61.81% |
| Dec 30, 2016 | 204.50M | 30.67% |
| Sep 29, 2016 | 156.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GRAIL | 1.92B |
| NeoGenomics | 1.03B |
| CareDx | 878.36M |
| OPKO Health | 859.83M |
| Personalis | 759.63M |
| Castle Biosciences | 743.28M |
| Burning Rock Biotech | 503.88M |
| Myriad Genetics | 428.27M |